Oncology Market with Covid-19 Effect Analysis, Research Report Analysis and Forecasts to 2025

by Montana Fleming

Overview of Oncology Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.

The global oncology market is subject to witness a substantial growth in upcoming years due to the high prevalence of cancer and increasing acceptance rate in the emerging markets. Increased prevalence of cancer can credited to the unhealthy lifestyle, and increasing geriatric population. These factors will have positive impact on market growth over the forecast period. Market growth is dependent on the potential of developing nations along with the rise in the number of pipeline products. Increasing importance of personalized medicines is predicted to fuel market growth over forecast period 2020-2025.

Gets Sample of Global Oncology Market Report @ https://www.arcognizance.com/enquiry-sample/1220707

The oncology market growth is important for general public as well as the business aspect as it helps to save the countless lives. Importance of market is measure on the behalf of number cases pertaining to cancer and prevalence across tumor types. The most recent result as per WHO data, there are approximately 18 million patients in the US alone by 2020, with a 31% increase from 13.8 million in 2010. This is reciprocated in global spending on therapeutic and supportive care with increased medical expenditure by countries all across the globe.

According to our analysis, the prostate cancer segment is one of the largest stake holders in the market. This has resulted in the largest oncology drugs market share in 2019. Prostate cancer is prevalent among the huge geriatric population. The lung cancer has shown massive progress due to the lifestyle changes, increased pollution and increased smoking among the youngsters. The technological developments and new R&D activities in the field of cancer diagnostics will increase market growth as well.

The global Oncology market is bifurcated on the basis of product, application, and geography. The product segment is further segmented into Chemotherapy, Targeted Therapy, Immunotherapy, and Hormonal Therapy. Based on Indication, the market is segmented into Lung Cancer, Stomach Cancer, Prostate Cancer, and Others. Geographically, the market is divided into North America, Europe, Asia-Pacific (APAC), Latin America, and Middle East & Africa (MEA). Based on application, market is segmented as Hospital, Clinics, and Others.

Since the CoVID-19 outbreak in December 2019, the virus has spread worldwide. CoVID-19 is impacting business globally and is further expected to influence this market as well. CoVID-19 has been affecting global supply chains and thereby throwing the demand and supply gap haywire, leaving significant financial impact. This report analyzes the impact of CoVID-19 on this industry and provides apt conclusions for key business stakeholders. The Oncology market has been further divided into key countries. Some of the key players operating in the market include Roche Holding AG, Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson Inc., Merck & Co. Inc., AstraZeneca PLC and Pfizer Inc.

Browse Global Oncology Industry Report @ https://www.arcognizance.com/report/oncology-market-global-industry-analysis-size-share-trends-and-forecast-2015-2025

Table of Content:

Chapter One: Market Introduction

Chapter Two: Executive Summary

Chapter Three: Global Oncology Market – Key Industry Dynamics

Chapter Four: Global Oncology Market – Analysis and Revenue Forecast, 2015-2025 – Product

  • 1. Chemotherapy
  • 2. Targeted Therapy
  • 3. Immunotherapy
  • 4. Hormonal Therapy

Chapter Five: Global Oncology Market – Analysis and Revenue Forecast, 2015-2025 – Indication

  • 1. Lung Cancer
  • 2. Stomach Cancer
  • 3. Prostate Cancer
  • 4. Others

Chapter Six: Global Oncology Market – Analysis and Revenue Forecast, 2015-2025 – Application

  • 1. Hospital
  • 2. Clinics
  • 3. Others

Chapter Seven: Global Oncology Market – Analysis and Revenue Forecast, 2015-2025 – By Region

  • 1. North America
  • 2. Europe
  • 3. Asia-Pacific
  • 4. Latin America
  • 5. Middle East & Africa

Chapter Eight: North America Oncology Market – Analysis and Revenue Forecast, 2015-2025

Chapter Nine: Europe Oncology Market – Analysis and Revenue Forecast, 2015-2025

Chapter Ten: Asia-Pacific Oncology Market – Analysis and Revenue Forecast, 2015-2025

Chapter Eleven: Latin America Oncology Market – Analysis and Revenue Forecast, 2015-2025

Chapter Twelve: Middle East & Africa Oncology Market – Analysis and Revenue Forecast, 2015-2025

Chapter Thirteen: Competitive Analysis

13.1.1. Competition Dashboard

13.1.2. Company Profiles

  • 1.2.1. Pfizer Inc
  • 1.2.1.1. Company Details
  • 1.2.1.2. Product Portfolio
  • 1.2.1.3. Financial Overview
  • 1.2.1.4. Main Business Overview
  • 1.2.1.5. News
  • 1.2.2. Roche Holding AG
  • 1.2.3. Novartis AG.
  • 1.2.4. Bristol-Myers Squibb Company.
  • 1.2.5. Johnson & Johnson.
  • 1.2.6. Merck & Co. Inc.
  • 1.2.7. AstraZeneca PLC co. ltd

Chapter Fourteen: Appendix

Chapter Fifteen: Research Conclusions

Make Enquiry of Oncology Market Report @ https://www.arcognizance.com/enquiry-before-buying/1220707
Buy Oncology Market Report @ https://www.arcognizance.com/purchase/1220707?license=single

About us: Analytical Research Cognizance (ARC) is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARC’s potential. ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:
Ranjeet Dengale
Director Sales
Analytical Research Cognizance
+1 (646) 403-4695, +91 90967 44448
sales@arcognizance.com

0 comment

Related Posts

Leave a Comment